AMN Healthcare (AMN) Q3 2026 Earnings Call Transcript

AMN Healthcare reported Q3 2026 revenue of $717M, up 13% YoY. Nurse and Allied revenue grew 16% YoY to $460M, driven by demand and operational improvements. Q4 revenue is projected to decline 13-15% YoY. Gross margin was 31.9%, and net income was $33M. The company expects long-term growth from workforce solutions and technology enhancements.

Original reporting
Published Nov 6, 2026, 4:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 5:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMN Healthcare (AMN) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMNNeutralHigh
01

Why it matters

The earnings release highlights robust Q3 growth but signals a slowdown in Q4, especially in travel nurse revenue due to visa bottlenecks.

02

Market read

First-report earnings with material numbers and guidance shift, offering immediate trading considerations.

03

What to watch

International visa delays and labor disruption revenue volatility may be temporary and not fully reflected in the stock price.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

AMN Healthcare provides staffing solutions to health systems, with segments including Nurse & Allied, Locum Tenens, and Technology services.

Company-level read

Ticker impact

$AMNNeutralHigh confidence
Context

Q3 2026 earnings released with $717M revenue, 13% YoY growth and guidance indicating Q4 revenue down 13-15% YoY.

Expected impact

likely modest pressure as investors price in lower Q4 guidance

Evidence & confidence

Strong Q3 results are offset by guidance for a revenue decline in the next quarter, creating mixed sentiment.

Market effects

Healthcare staffing sector may see heightened scrutiny on future demand and labor disruption impacts.

U.S. healthcare staffing stocks could experience short-term volatility.

Limited to U.S. and international staffing firms with similar exposure.

Counterpoint

Despite Q4 revenue decline guidance, the strong Q3 performance and AI recruiting improvements could support a longer-term upside.

Key entities

  • AMN Healthcare

    U.S.-listed healthcare staffing firm (ticker AMN).

Related articles

$AMNMedAI 8/10

AMN Q3 2026 deep dive: strong Nurse and Allied demand offsets international headwinds

AMN Healthcare Services reported Q3 2026 revenue of $717.3M, beating estimates by 10.5%, with adjusted EPS of $1.16 vs. $0.23 expected. Adjusted EBITDA was $93.57M, significantly above estimates. Nurse and Allied demand surged, while international nurse staffing faced headwinds. Q4 guidance is $662.5M, above estimates. Management highlighted one-time margin benefits and ongoing tech and international risks.

$AMNMedAI 8/10

AMN Healthcare Services Q3 Earnings Call Highlights

AMN Healthcare Services reported Q3 results, with international nurse revenue up 32% YoY but expecting declines due to visa delays. Physician and Leadership Solutions revenue fell 4% YoY, while locum tenens revenue declined 5%. Technology and Workforce Solutions revenue dropped 9%. AMN projects Q4 revenue of $655M-$670M, with Nurse and Allied revenue expected to decline 13%-15% YoY. The company has $256M in cash and $750M in debt.